Axonal regeneration and neuroinflammation: roles for the translocator protein 18 kDa
- PMID: 21951109
- DOI: 10.1111/j.1365-2826.2011.02215.x
Axonal regeneration and neuroinflammation: roles for the translocator protein 18 kDa
Abstract
After a traumatic injury of the nervous system or in the course of a neurodegenerative disease, the speed of axonal regeneration and the control of the inflammatory response are fundamental parameters of functional recovery. Spontaneous regeneration takes place in the peripheral nervous system, although the process is slow and often incomplete. There is currently no efficient treatment for enhancing axonal regeneration, including elongation speed and functional reinnervation. Ligands of the translocator protein 18 kDa (TSPO) are currently under investigation as therapeutic means for promoting neuroprotection, accelerating axonal regeneration and modulating inflammation. The mechanisms of action of TSPO ligands involve the regulation of mitochondrial activity and the stimulation of steroid biosynthesis. In the peripheral nervous system, TSPO expression is strongly up-regulated after injury, primarily in Schwann cells and macrophages, but also in neurones. Its levels return to low control values when nerve regeneration is completed, strongly supporting an important role in regenerative processes. We have demonstrated a role for the benzoxazine etifoxine in promoting axonal regeneration in the lesioned rat sciatic nerve, either after freeze-injury or complete transection. Etifoxine is already clinically approved for the treatment of anxiety disorders (Stresam(®) , Biocodex, Gentilly, France). Daily treatment with etifoxine resulted in a two-fold acceleration in axonal regeneration, as well as in a marked improvement of both the speed and quality of functional recovery. The neuroregenerative effects of etifoxine are likely to be mediated by TSPO, and they may involve an increased synthesis of pregnenolone and its metabolites, such as progesterone. After freeze-injury of the sciatic nerve, administration of etifoxine also strongly reduced the number of activated macrophages and decreased the production of the inflammatory cytokines tumour necrosis factor-α and interleukin-1β. Thus, this drug offers promise for the treatment of peripheral nerve injuries and axonal neuropathies. It may also be used as a lead compound in the development of new TSPO-based neuroprotective approaches.
© 2011 The Authors. Journal of Neuroendocrinology © 2011 Blackwell Publishing Ltd.
Similar articles
-
Etifoxine improves peripheral nerve regeneration and functional recovery.Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20505-10. doi: 10.1073/pnas.0811201106. Epub 2008 Dec 15. Proc Natl Acad Sci U S A. 2008. PMID: 19075249 Free PMC article.
-
Myelin-associated glycoprotein reduces axonal branching and enhances functional recovery after sciatic nerve transection in rats.Glia. 2007 Nov 1;55(14):1498-507. doi: 10.1002/glia.20566. Glia. 2007. PMID: 17705198
-
The pros and cons of growth factors and cytokines in peripheral axon regeneration.Int Rev Neurobiol. 2013;108:137-71. doi: 10.1016/B978-0-12-410499-0.00006-X. Int Rev Neurobiol. 2013. PMID: 24083434 Review.
-
Etifoxine improves sensorimotor deficits and reduces glial activation, neuronal degeneration, and neuroinflammation in a rat model of traumatic brain injury.J Neuroinflammation. 2016 Aug 26;13(1):203. doi: 10.1186/s12974-016-0687-3. J Neuroinflammation. 2016. PMID: 27565146 Free PMC article.
-
Role of macrophages in Wallerian degeneration and axonal regeneration after peripheral nerve injury.Acta Neuropathol. 2015 Nov;130(5):605-18. doi: 10.1007/s00401-015-1482-4. Epub 2015 Sep 29. Acta Neuropathol. 2015. PMID: 26419777 Review.
Cited by
-
Effect of ZBD-2 on chronic pain, depressive-like behaviors, and recovery of motor function following spinal cord injury in mice.Behav Brain Res. 2017 Mar 30;322(Pt A):92-99. doi: 10.1016/j.bbr.2017.01.025. Epub 2017 Jan 18. Behav Brain Res. 2017. PMID: 28108322 Free PMC article.
-
Etifoxine for pain patients with anxiety.Korean J Pain. 2015 Jan;28(1):4-10. doi: 10.3344/kjp.2015.28.1.4. Epub 2015 Jan 2. Korean J Pain. 2015. PMID: 25589941 Free PMC article. Review.
-
Translocator protein (18 kDa) (TSPO) is expressed in reactive retinal microglia and modulates microglial inflammation and phagocytosis.J Neuroinflammation. 2014 Jan 8;11:3. doi: 10.1186/1742-2094-11-3. J Neuroinflammation. 2014. PMID: 24397957 Free PMC article.
-
Microglial activation mediates chronic mild stress-induced depressive- and anxiety-like behavior in adult rats.J Neuroinflammation. 2018 Jan 17;15(1):21. doi: 10.1186/s12974-018-1054-3. J Neuroinflammation. 2018. PMID: 29343269 Free PMC article.
-
Translocator protein (18 kDa): an update on its function in steroidogenesis.J Neuroendocrinol. 2018 Feb;30(2):10.1111/jne.12500. doi: 10.1111/jne.12500. J Neuroendocrinol. 2018. PMID: 28667781 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical